Home » Topics » Regulatory

Regulatory
RSS

NeoRx's Verluma approved for U.S. market

Aug. 23, 1996

Aredia earns U.S. approval for new indication

Aug. 23, 1996

Ethyol extended labeling approved

Aug. 23, 1996

European approval sought for new Rebif indications

Aug. 23, 1996

Biaxin shown to prolong longetivity in AIDS patients

Aug. 23, 1996

Zithromax demonstrates prophylactic effect against MAC in AIDS patients

Aug. 23, 1996

TheraTech studies oral mucosal delivery system for GLP-1

Aug. 16, 1996

Marinol potential in Alzheimer's disease patients reported at congress

Aug. 16, 1996

Lamotrigine, valproate tested in mood disorders

Aug. 16, 1996

Letrozole approved for marketing in France

Aug. 16, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 10, 2026.
Ionis, AZ shares down on unexpected Wainua flop in cardiomyopathy
BioWorld
News of the unexpected phase III failure of the gene silencing drug Wainua (eplontersen) in the treatment of transthyretin-mediated amyloid cardiomyopathy sent...
FENS 2026: Next-gen biologics take on brain disease
BioWorld
Whether by fine-tuning neurotransmitter signaling or silencing disease-associated genes, emerging biologic therapies are reshaping neuroscience drug development,...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
NRF2 activators reported in Vailima Peninsula patent
BioWorld Science
Vailima Peninsula Pty Ltd. has discovered new nuclear factor erythroid 2-related factor 2 (NFE2L2; NRF2) activators potentially useful for the treatment of...